| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/21/2011 | CN101530414B Applications of compound ketanserin |
| 09/21/2011 | CN101530388B Formulation of mildronate injection and preparation method |
| 09/21/2011 | CN101502529B Application of vincetoxicoside B in preparing antidiabetic medicament |
| 09/21/2011 | CN101497593B 5-hydroxy coumarin and pyranoid type coumarin compounds, synthesizing method and use |
| 09/21/2011 | CN101491511B Use of Hirsutanols A in preparing anti-tumor medicine |
| 09/21/2011 | CN101454295B Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep |
| 09/21/2011 | CN101448839B A process for the preparation of a taxane derivative |
| 09/21/2011 | CN101406641B Compound medicament for treating vitiligo |
| 09/21/2011 | CN101389612B 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
| 09/21/2011 | CN101385826B Health care medicinal liquor for strenthening yang and preparation method thereof |
| 09/21/2011 | CN101365430B Adenosine a3 receptor agonists for the treatment of dry eye disorders |
| 09/21/2011 | CN101355969B Antiproliferative combination comprising CYC-682 and a cytotoxic agent |
| 09/21/2011 | CN101346137B Combination comprising combretastatin and anticancer agents |
| 09/21/2011 | CN101343250B Thrombopoietin mimetics |
| 09/21/2011 | CN101306100B Medicine from external application for treating periglandular aphtha |
| 09/21/2011 | CN101306090B Nasal fumigation medicaments for treating chronic simple rhinitis |
| 09/21/2011 | CN101274067B Method of medical ointment for activating blood circulation, removing stasis, dredging channels and collaterals, releasing swelling and relieving pain |
| 09/21/2011 | CN101268074B 5-amino-4-hydroxy-7- (imidazo [1,2-A] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 09/21/2011 | CN101249084B Disinfection composing prescription of preventability transmitted diseases |
| 09/21/2011 | CN101242818B Use of a combination comprising L-carnitine or alkanoyl L-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the |
| 09/21/2011 | CN101225085B Phenyl urazan nitrogen nitric oxide donor 2-aniline pyrimidine derivatives, preparation method, compound containing the same and use thereof |
| 09/21/2011 | CN101224217B Skeleton type roxithromycin sustained release pellet capsule |
| 09/21/2011 | CN101222913B Pharmaceutical composition comprising 2 , 3-dihydro-6-nitroimidazo [2 , 1-B] oxazole derivatives |
| 09/21/2011 | CN101214253B Application of anemarrhenasaponin B-II in preparing antidepressant product |
| 09/21/2011 | CN101204524B Tincture medicine for migraine |
| 09/21/2011 | CN101204452B Tincture medicine for verruca plana |
| 09/21/2011 | CN101204410B External medicine for vitligo |
| 09/21/2011 | CN101199688B Tincture dose medicament for treating part frozen |
| 09/21/2011 | CN101199589B Tincture medicament for treating face vifiligo |
| 09/21/2011 | CN101195010B Powder medicament for treating acute soft tissue injury |
| 09/21/2011 | CN101194994B Externally used medicament for treating toothache |
| 09/21/2011 | CN101194992B Plaster medicament for treating thrush of baby |
| 09/21/2011 | CN101181372B Method for preparing alcohol extract of tibetan medicine Qing-peng slurry |
| 09/21/2011 | CN101166534B Therapeutic agent for chronic obstructive pulmonary disease |
| 09/21/2011 | CN101132795B Compounds useful in the treatment of HIV |
| 09/21/2011 | CN101111240B Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperp |
| 09/21/2011 | CN101085785B Purine compounds for curing hepatitis B, preparation method and use thereof, and composition containing the compounds |
| 09/21/2011 | CN101085070B Traditional Chinese medicinal composition containing notoginseng and haw and its preparation |
| 09/21/2011 | CN101085027B Traditional Chinese medicinal composition containing red sage root and kudzuvine root and its preparation |
| 09/21/2011 | CN101085025B Medicinal composition containing red sage root and safflower, preparation method and preparation |
| 09/21/2011 | CN101031290B Modafinil modified release pharmaceutical compositions |
| 09/21/2011 | CN101010066B Stabilised prostaglandin composition |
| 09/20/2011 | US8022279 Liposomal formulations of anthracycline agents and cytidine analogs |
| 09/20/2011 | US8022250 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 09/20/2011 | US8022249 Compounds for the treatment of metabolic disorders |
| 09/20/2011 | US8022246 Neuroprotective compositions and methods |
| 09/20/2011 | US8022234 Compounds and compositions |
| 09/20/2011 | US8022232 Method for manufacture of escitalopram |
| 09/20/2011 | US8022226 Nonsedating α-2 agonists |
| 09/20/2011 | US8022222 Glucokinase activators |
| 09/20/2011 | US8022221 Aurora kinase modulators and method of use |
| 09/20/2011 | US8022220 Process for production of piperidine derivatives |
| 09/20/2011 | US8022219 2-hydroxymethy1-3,4,5-trihydroxy-1-(4-pentyloxybenzyl) piperidine as glucosylceramide synthase (Gcs) inhibitor |
| 09/20/2011 | US8022213 6'-Bromo-1-[(5-methoxy-3-methyl-1H-indol-2-yl)carbonyl]-1'H-spiro[piperidine-4,4'-quinolin]-2'(3'H)-one; vasopressin receptors antagonist; antidepressant, anxiolytic agent; inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder |
| 09/20/2011 | US8022208 Benzene derivative or salt thereof |
| 09/20/2011 | US8022203 Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes |
| 09/20/2011 | US8022192 Process for production of glucopyranosyloxypyrazole derivative |
| 09/20/2011 | US8022179 Compositions and methods for topical application and transdermal delivery of an oligopeptide |
| 09/20/2011 | US8022174 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 09/20/2011 | US8022106 Tranexamic acid formulations |
| 09/20/2011 | US8022105 Prevention of neutrophil recruitment |
| 09/20/2011 | US8022104 Formulations of ladostigil tartrate |
| 09/20/2011 | US8022102 Unsaturated tetracyclic tetrahydrofuran derivatives |
| 09/20/2011 | US8022101 Method of treating a knee meniscus with a cross-linking reagent to increase resistance to tearing or rupturing |
| 09/20/2011 | US8022100 Whitening agents for cellulosic substrates |
| 09/20/2011 | US8022099 N-benzyl pyrrolidine derivatives |
| 09/20/2011 | US8022098 Deuterated aminocyclohexyl ether compounds and processes for preparing same |
| 09/20/2011 | US8022097 Adamantane-dipyrromethane derivatives, method of preparation and applications in anion sensing |
| 09/20/2011 | US8022096 Pyrrolidine derivatives |
| 09/20/2011 | US8022095 Comprises sumatriptan and naproxen as non-steroidal antiinflammatory agents (NSAIDS) |
| 09/20/2011 | US8022093 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof |
| 09/20/2011 | US8022092 (2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors |
| 09/20/2011 | US8022091 Triazole derivative |
| 09/20/2011 | US8022090 Vitamin C composition stabilized with cationic material, anionic material and caffeic acid derivative |
| 09/20/2011 | US8022089 Isoxazoline-substituted benzamide compound and pesticide |
| 09/20/2011 | US8022088 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 09/20/2011 | US8022087 Derivatives of pyridone and use thereof |
| 09/20/2011 | US8022086 Therapeutic agent for glomerular disease |
| 09/20/2011 | US8022085 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 09/20/2011 | US8022084 Polymorphic forms of a GABAA agonist |
| 09/20/2011 | US8022083 Antiviral phosphonate analogs |
| 09/20/2011 | US8022082 Method for the administration of an anticholinergic by inhalation |
| 09/20/2011 | US8022081 Naphthyl substituted azabicyclo derivatives and their use as monomine neurotransmitter re-uptake inhibitors |
| 09/20/2011 | US8022080 Small molecules with antiprotozoal activity |
| 09/20/2011 | US8022079 Methods of modulating PPAR gamma-type receptors |
| 09/20/2011 | US8022078 Pyrimidine classical cannabinoid compounds and related methods of use |
| 09/20/2011 | US8022077 Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof |
| 09/20/2011 | US8022076 Thieno[2,3-d]pyrimidine derivatives as potassium channel modulators; antiarrhythmia agents |
| 09/20/2011 | US8022075 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 09/20/2011 | US8022074 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/20/2011 | US8022073 Substituted pyridazine compounds and fungicidal uses thereof |
| 09/20/2011 | US8022072 Azolylmethylidenehydrazine derivative and use thereof |
| 09/20/2011 | US8022071 Nitrogenous heterocyclic compounds |
| 09/20/2011 | US8022069 Substituted piperidines as renin inhibitors |
| 09/20/2011 | US8022068 Substituted piperidines as renin inhibitors |
| 09/20/2011 | US8022066 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes |
| 09/20/2011 | US8022065 Purine derivatives as kinase inhibitors |
| 09/20/2011 | US8022064 Phenylpentadienoyl derivatives and their use as PAR 1 antagonists |
| 09/20/2011 | US8022063 CRTH2 receptor ligands for medicinal uses |
| 09/20/2011 | US8022062 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |